Literature DB >> 21526010

Do we have a diabetes epidemic in Libya?

Omran Bakoush1, Targ Elgzyri.   

Abstract

Entities:  

Year:  2006        PMID: 21526010      PMCID: PMC3081352          DOI: 10.4176/061016

Source DB:  PubMed          Journal:  Libyan J Med        ISSN: 1819-6357            Impact factor:   1.657


× No keyword cloud information.
It is estimated by the World Health Organization (WHO) that 3% of the world's population (194 million) have diabetes and the prevalence is expected to double by the year 2025 to 6.3% [1]. According to WHO, it is estimated that there were 88,000 diabetics in Libya the year 2000. This prevalence is estimated to reach 245,000 diabetics by the year 2030, (see figure below). In Libya, according to local epidemiological studies, the prevalence for known diabetic patients aged over 20 years was 3.8% [2]. As 50% of type 2 diabetic patients are unaware of their diabetes “undiagnosed”, the actual prevalence is probably higher. Figure showing the estimated prevalence of diabetes mellitus of adults in 2030 as compared with data from the year 2000. Reprinted with permission from The American Diabetes Association. Reference: Diabetes Care, Vol. 27, 2004; 1047–1053. In the town of Tajoura, the west part of Libya; 7.9% of all adult members of 1094 randomly selected families (2996 persons aged between 20 and 75 years) had diabetes [3]. In Benghazi, in the eastern part of Libya, screening of a randomly selected group of 868 subjects revealed that about 23% above age of 20 years were glucose intolerant, two-thirds had diabetes and the rest had impaired glucose tolerance [4]. From these two Libyan cohorts, we estimate the adult diabetic population in Libya to be at least 300,000 at present. In addition, these studies showed that only 18% of Libyans practice any form of physical exercise and more than 69% have a BMI of more than 25 kg/m2 [3]. The sedentary life style and obesity are clearly the major contributing factors for the diabetes epidemic. The cost of health care: The average annual heath care cost for a patient with type 2 diabetes in Sweden is ~ 2700 Euros [5]. 42% of this cost was for in hospitalisation cost and 31% for ambulatory care visits. Only 2% of the cost was for anti-diabetic drugs. In Spain the direct cost per diabetic per capita per year estimated to be 50% of Swedish cost (~1300 Euros) [6]. In comparison to Spain, we estimate at least 400 million Euros will be needed annually to deliver an optimal diabetes care for the 300,000 Libyan diabetic population [4, 7, 8]. In summary: This huge diabetic load seriously threatens the country's health service. However, due to differences in standards of living, our cost estimates may not be appropriate for Libya, and carefully planned epidemiological and economic studies should be seriously considered. Public education to increase the physical activity and to normalize the carbohydrate load are important actions to be taken to limit the diabetes epidemic [9].
  8 in total

Review 1.  Origins and evolution of the Western diet: health implications for the 21st century.

Authors:  Loren Cordain; S Boyd Eaton; Anthony Sebastian; Neil Mann; Staffan Lindeberg; Bruce A Watkins; James H O'Keefe; Janette Brand-Miller
Journal:  Am J Clin Nutr       Date:  2005-02       Impact factor: 7.045

Review 2.  [Increasing number of dialysis-requiring patients with diabetic nephropathies. Better diabetes control and antihypertensive treatment can counteract the trend].

Authors:  Jan Kurkus; Staffan Schön; Karl-Göran Prütz; Ole Torffvit
Journal:  Lakartidningen       Date:  2005 May 2-15

3.  Epidemiological and clinical patterns of diabetes mellitus in Benghazi, Libyan Arab Jamahiriya.

Authors:  O A Kadiki; R B Roaed
Journal:  East Mediterr Health J       Date:  1999-01       Impact factor: 1.628

4.  Direct health care costs of diabetic patients in Spain.

Authors:  Juan Oliva; Félix Lobo; Begoña Molina; Susana Monereo
Journal:  Diabetes Care       Date:  2004-11       Impact factor: 19.112

5.  Prevalence of diabetes mellitus and impaired glucose tolerance in Benghazi Libya.

Authors:  O A Kadiki; R B Roaeid
Journal:  Diabetes Metab       Date:  2001-12       Impact factor: 6.041

6.  Direct medical costs for patients with type 2 diabetes in Sweden.

Authors:  F Henriksson; C D Agardh; C Berne; J Bolinder; F Lönnqvist; P Stenström; C G Ostenson; B Jönsson
Journal:  J Intern Med       Date:  2000-11       Impact factor: 8.989

7.  Preventive strategies of renal failure in the Arab world.

Authors:  Faissal A M Shaheen; Abdullah A Al-Khader
Journal:  Kidney Int Suppl       Date:  2005-09       Impact factor: 10.545

8.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

  8 in total
  6 in total

1.  The need for co-ordinated studies for obesity-related problems like diabetes mellitus in Libyan population.

Authors:  Dhastagir S Sheriff; Abdul Aziz Alshaari; Thiruvagounder Manopriya
Journal:  Libyan J Med       Date:  2012-03-22       Impact factor: 1.657

2.  Libyan National Health Services The Need to Move to Management-by-Objectives.

Authors:  A El Taguri; Ea Elkhammas; O Bakoush; N Ashammakhi; M Baccoush; I Betilmal
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

3.  Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study.

Authors:  Fi Najem; Rr Elmehdawi; Am Swalem
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

4.  Fasting of Ramadan in peoples with diabetes in Benghazi, Libya: an exploratory study.

Authors:  Rafik Ramadan Elmehdawi; Nama Ali Mukhtad; Najla Ibrahim Allaghi; Suhair Jaber Elmajberi
Journal:  Libyan J Med       Date:  2010-03-04       Impact factor: 1.657

5.  The epidemiology of chronic pain in Libya: a cross-sectional telephone survey.

Authors:  Raga A Elzahaf; Mark I Johnson; Osama A Tashani
Journal:  BMC Public Health       Date:  2016-08-11       Impact factor: 3.295

6.  Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.

Authors:  Sabri Garoushi; Mark I Johnson; Osama A Tashani
Journal:  Libyan J Med       Date:  2017-12       Impact factor: 1.657

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.